Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
SAFETY AND EFFICACY OF LANREOTIDE DEPOT VS PLACEBO IN NEUROENDOCRINE TUMOR PATIENTS WITH A HISTORY OF CARCINOID SYNDROME AND PRIOR OCTREOTIDE THERAPY. Williams, D., Vinik, A., Wolin, E., Kunz, P., Lowenthal, S., Fisher, G. ONCOLOGY NURSING SOC. 2016: 133–34
View details for Web of Science ID 000373613900379